Home/Pipeline/MADx ALEX2 Allergy Explorer

MADx ALEX2 Allergy Explorer

Allergen sensitization (IgE detection)

Approved/CommercialMarketed (RUO in US)

Key Facts

Indication

Allergen sensitization (IgE detection)

Phase

Approved/Commercial

Status

Marketed (RUO in US)

Company

ALPCO Diagnostics

About ALPCO Diagnostics

Founded in 1991 as the American Laboratory Products Company, ALPCO has evolved from a distributor into a leading global diagnostics firm. Its strategic merger with GeneProof in April 2022 significantly expanded its capabilities in molecular diagnostics. The company now provides integrated platforms for immunodiagnostics and PCR-based molecular diagnostics, serving clinical and research laboratories with high-quality, automated testing solutions.

View full company profile

Therapeutic Areas

Infectious Disease Gastroenterology Specialty Allergy Immunology Diabetes & Obesity Endocrinology

Other Allergen sensitization (IgE detection) Drugs

Drug	Company	Phase	Status
MADx ALEX3 Allergy Explorer	ALPCO Diagnostics	Approved/Commercial	Marketed (Health Canada Licensed)